A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris
- Conditions
- Acne Vulgaris
- Interventions
- Registration Number
- NCT00664248
- Lead Sponsor
- Dow Pharmaceutical Sciences
- Brief Summary
The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1414
- Presence of inflammatory and non-inflammatory lesions
- Dermatological conditions of the face other than acne that could interfere with clinical evaluations
- Female subjects who are pregnant, nursing, planning a pregnancy, or become pregnant during the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 IDP-110 - 4 Vehicle - 3 Benzoyl peroxide - 2 Clindamycin -
- Primary Outcome Measures
Name Time Method Change from baseline in number of lesions 12 weeks
- Secondary Outcome Measures
Name Time Method Change from baseline in global severity 12 weeks
Trial Locations
- Locations (35)
Total Skin and Beauty Dermatology Center
🇺🇸Birmingham, Alabama, United States
University of Alabama, Birmingham
🇺🇸Birmingham, Alabama, United States
Medical Affiliated Research Center, Inc.
🇺🇸Huntsville, Alabama, United States
Dermatology Research of Arkansas
🇺🇸Little Rock, Arkansas, United States
Affiliated Research Institute - Dermatology
🇺🇸San Diego, California, United States
Therapeutics Clinical Research
🇺🇸San Diego, California, United States
University of California, San Diego, Pediatric and Adolescent Dermatology
🇺🇸San Diego, California, United States
Solano Clinical Research
🇺🇸Vallejo, California, United States
Dermatology Specialists, Inc.
🇺🇸Vista, California, United States
Clinical Research Specialists
🇺🇸West Santa Monica, California, United States
Scroll for more (25 remaining)Total Skin and Beauty Dermatology Center🇺🇸Birmingham, Alabama, United States